Ming Liang Li
Chairman at IBT II Venture Capital Co., Ltd.
Profile
Dr. Ming Liang Li is Chairman at Boston Life Science Venture Co. and Chairman at IBT II Venture Capital Co., Ltd.
He is on the Board of Directors at Reber Genetics Co., Ltd., Taiwan Research-based Biopharmaceutical Manufacturers Assoc, Taiwan Global BioFund, and Industrial Bank of Taiwan Co. Ltd.
/Private Group/.
Dr. Li was previously employed as Independent Director by China Bills Finance Corp.
and a Professor by Tzu Chi University.
He received his doctorate degree from Miami University (Ohio).
Ming Liang Li active positions
| Companies | Position | Start |
|---|---|---|
IBT II Venture Capital Co., Ltd.
 IBT II Venture Capital Co., Ltd. Investment ManagersFinance IBT II Venture Capital Co. Ltd. invests in companies located in Taiwan, the US, China, South East Asia, and Europe. The fund targets companies operating in the fields of consumer electronics, communications, semiconductors, optoelectronics, networking, computers, biotechnology, pharmaceuticals, healthcare services, green energy and environmental services. It provides financing for expansion, early and later stage capital requirements. | Chairman | - |
| Taiwan Research-based Biopharmaceutical Manufacturers Assoc | Director/Board Member | - |
Taiwan Global BioFund
 Taiwan Global BioFund Investment ManagersFinance Taiwan Global BioFund invests exclusively in life science companies located in Taiwan and US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals, diagnostics, medical devices, medical services, and medical informatics. It provides financing for seed, early and later stage capital requirements. | Director/Board Member | - |
Industrial Bank of Taiwan Co. Ltd. /Private Group/
 Industrial Bank of Taiwan Co. Ltd. /Private Group/ Financial ConglomeratesFinance Industrial Bank of Taiwan Co. Ltd. is led by a private group. | Director/Board Member | - |
Former positions of Ming Liang Li
| Companies | Position | End |
|---|---|---|
| CHINA BILLS FINANCE CORPORATION | Director/Board Member | 2012-06-18 |
| REBER GENETICS CO LTD | Director/Board Member | - |
Boston Life Science Venture Co.
 Boston Life Science Venture Co. Investment ManagersFinance Boston Life Science Venture Co. is a venture capital fund. The company is based in Taipei, Taiwan. | Chairman | - |
| Tzu Chi University | Corporate Officer/Principal | - |
Training of Ming Liang Li
| Miami University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CHINA BILLS FINANCE CORPORATION | Finance |
| Private companies | 6 |
|---|---|
Boston Life Science Venture Co.
Boston Life Science Venture Co. Investment ManagersFinance Boston Life Science Venture Co. is a venture capital fund. The company is based in Taipei, Taiwan. | Finance |
IBT II Venture Capital Co., Ltd.
IBT II Venture Capital Co., Ltd. Investment ManagersFinance IBT II Venture Capital Co. Ltd. invests in companies located in Taiwan, the US, China, South East Asia, and Europe. The fund targets companies operating in the fields of consumer electronics, communications, semiconductors, optoelectronics, networking, computers, biotechnology, pharmaceuticals, healthcare services, green energy and environmental services. It provides financing for expansion, early and later stage capital requirements. | Finance |
Taiwan Global BioFund
Taiwan Global BioFund Investment ManagersFinance Taiwan Global BioFund invests exclusively in life science companies located in Taiwan and US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals, diagnostics, medical devices, medical services, and medical informatics. It provides financing for seed, early and later stage capital requirements. | Finance |
| Taiwan Research-based Biopharmaceutical Manufacturers Assoc | |
Reber Genetics Co., Ltd.
 Reber Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Reber Genetics Co., Ltd. engages in the research, development, production, and sale of animal vaccines. Its products include PRRS and PCV2 subunit vaccines. The company was founded on April 18, 2008 and is headquartered in Taipei, Taiwan. | Health Technology |
Industrial Bank of Taiwan Co. Ltd. /Private Group/
Industrial Bank of Taiwan Co. Ltd. /Private Group/ Financial ConglomeratesFinance Industrial Bank of Taiwan Co. Ltd. is led by a private group. | Finance |
- Stock Market
- Insiders
- Ming Liang Li